Latest Vietnam News

Comms Group Limited reported record FY26 revenue and EBITDA growth, driven by organic expansion and TasmaNet acquisition, while progressing the $30m sale of its ICT business to streamline operations and support shareholder returns.

Memphasys has cleared a key regulatory hurdle in Vietnam for its Felix™ System, prompting a significant first commercial cartridge order and marking early clinical success in a fast-growing fertility market.

Breville Group delivered record FY26 revenue of AUD 1.81 billion and EBIT of AUD 207 million, navigating tariff volatility and currency headwinds while completing a major manufacturing diversification.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

Sparc Technologies has secured commercial traction for its graphene additive ecosparc® with major coatings players AkzoNobel and Petro Vietnam Paint, launched a new additive range for electrostatic coatings, and marked six months of continuous operation at its green hydrogen pilot plant.

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

EVZ Limited closed FY26 with a net positive operating cash flow of $10.1 million and an $18.3 million cash balance, while maintaining a robust $80 million contract backlog and progressing several acquisition opportunities for FY27.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Recce Pharmaceuticals has expanded its intellectual property footprint with a key patent granted in Vietnam for its RECCE® anti-infective drugs, reinforcing its presence in a critical Southeast Asian market grappling with high antibiotic resistance.

Critica Limited’s recent drilling at its Jupiter Rare Earth Project has validated broad, near-surface high-grade zones, underpinning an imminent resource upgrade and advancing its scoping study.

Fluence Corporation has secured two seawater desalination contracts in Vietnam worth approximately US $3.7 million. The projects, set for completion by year-end 2026, will produce up to 7,500 cubic metres of potable water daily on Phu Quoc Island, addressing critical water scarcity.